CClinicalTrials.gg
CompletedNCT03545581Updated Apr 22, 2019

Fructose Supplementation in Carriers for Hereditary Fructose Intolerance

An interventional study of Experimental diet Fru rich diet and Experimental low Fru diet in Hereditary Fructose Intolerance, sponsored by University of Lausanne. Completed at 1 site in Belgium. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-04-22.

Sponsored by University of Lausanne · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study aimed to examine metabolic response to a short-term fructose enriched diet in carriers for hereditary fructose intolerance compared to controls. Effects of fructose coffees will be assessed in 7 healthy volunteers and 7 subjects with heterozygous mutation for ALDOB gene in a randomized, controlled, crossover trial.

Read the detailed description

A high fructose intake also increases blood lactate and uric acid concentrations. It has been proposed that uric acid may contribute to insulin resistance by impairing endothelium-dependent vasodilation, promoting pro-inflammatory effects and dyslipidemia by activating de novo lipogenesis.

These consequences of fructose overconsumption may be even more marked in individuals with hereditary alterations in fructose metabolism. Indeed, individuals with hereditary fructose intolerance (HFI), due to biallelic mutations in the gene coding for aldolase B (ALDOB), may develop acute, life-threatening manifestations when exposed to fructose. Heterozygous carriers of ALDOB mutation are quite common in the general population, with a predicted frequency ranging between 1:55 and 1:120. Few studies have examined the effect of fructose ingestion in heterozygotes subject for HFI. Heterozygous carriers are generally considered to have normal fructose metabolism since a \~ 50% level of aldolase B activity is presumed to be sufficient for adequate function. However, heterozygous carriers were reported to have enhanced uric acid responses to large intravenous and/or oral fructose loads.

Investigators hypothesized that heterozygous carriers may also have mild defects of fructose metabolism and/or a larger increase in cardiometabolic risk factors than the normal population after ingestion of moderate amounts of fructose.

02

Conditions studied

  • Hereditary Fructose Intolerance

Keywords

  • Fructose
  • Uric acid
  • Glucose homeostasis
03

In context

Lead sponsor

University of Lausanne is the lead sponsor of 54 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Case subjects: Heterozygous carriers for ALDOB mutation confirmed by molecular analysis
  • Control subjects: healthy individuals matched for weight and age to subjects

Exclusion criteria

Exclusion Criteria:

  • Fasting glucose > 7.0 mmol/L
  • Fasting triglycerides > 4.0 mmol/L
  • Chronic renal insufficiency (eGFR \< 50 ml/min)
  • Drugs
  • Women who are pregnant or breast feeding
  • For women: lack of safe contraception
  • Alcool consumption > 30g/d
  • Inability to discern
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
12 participants (actual)

Study arms

  • Other
    Experimental diet Fru rich diet

    Enriched fructose diet from day 1 to day 7.

    Other: Experimental diet Fru rich diet

  • Other
    Experimental low Fru diet

    Low fructose diet from day 1 to day 7.

    Other: Experimental low Fru diet

Interventions

  • OtherExperimental diet Fru rich diet

    7 days (day 1 to day 7) with fructose enriched drinks 3x/d. Test meal at day 7 with fructose (0.7 g/body weight) and glucose (0.7 g/body weight)

  • OtherExperimental low Fru diet

    7 days (day 1 to day 7) with low-fructose diet (\<10g/d). Test meal at day 7 with fructose (0.7 g/body weight) and glucose (0.7 g/body weight)

06

What researchers measure

Primary outcomes

  1. Metabolite concentration

    The primary endpoint is the change of metabolite concentration after ingestion of a test meal (oral glucose and fructose load) under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

    Time frame: Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal

Secondary outcomes

  1. Plasma glucose concentration

    Change in glucose concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

    Time frame: Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal

  2. Plasma insulin concentration

    Change in insulin concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

    Time frame: Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal

  3. Plasma fructose concentration

    Change in fructose concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

    Time frame: Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal

  4. Plasma uric acid concentration

    Change in uric acid concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

    Time frame: Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal

  5. Plasma lactate concentration

    Change in lactate concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

    Time frame: Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal

  6. Plasma urea concentration

    Change in urea concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

    Time frame: Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal

  7. Plasma creatinine concentration

    Change in creatinine concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

    Time frame: Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal

  8. Plasma phosphate concentration

    Change in phosphate concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

    Time frame: Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal

  9. Plasma triglycerides concentration

    Change in triglycerides concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

    Time frame: Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal

  10. Plasma metabolome concentration

    Change in metabolome concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

    Time frame: Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal

  11. Plasma ammonia concentration

    Change in ammonia concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

    Time frame: Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal

  12. Plasma amino acid concentration

    Change in amino acid concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

    Time frame: Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal

  13. Plasma alanine transaminase (ALAT) concentration

    Change in alanine transminase (ALAT) concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

    Time frame: Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal

  14. Plasma aspartate transaminase (ASAT) concentration

    Change in aspartate transaminase (ASAT) concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

    Time frame: Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal

  15. Urine metabolome concentration

    Change in urine metabolome profile after low fructose diet and an enriched fructose diet according to a crossover design

    Time frame: Time Frame: 24 hour urine collection before ingestion of a test meal and after 7 days of 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

  16. Urine creatinine concentration

    Change in urine creatinine profile after low fructose diet and an enriched fructose diet according to a crossover design

    Time frame: Time Frame: 24 hour urine collection before ingestion of a test meal and after 7 days of 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

  17. Urine urea concentration

    Change in urine urea profile after low fructose diet and an enriched fructose diet according to a crossover design

    Time frame: Time Frame: 24 hour urine collection before ingestion of a test meal and after 7 days of 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

  18. Urine uric acid concentration

    Change in urine uric acid profile after low fructose diet and an enriched fructose diet according to a crossover design

    Time frame: Time Frame: 24 hour urine collection before ingestion of a test meal and after 7 days of 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

  19. Body weight

    Change of body weight after low fructose diet and an enriched fructose diet according to a crossover design

    Time frame: Time Frame: at baseline before study intervention and at the end of each conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

  20. Blood pressure

    Change of systolic and diastolic pressure after low fructose diet and an enriched fructose diet according to a crossover design

    Time frame: Time Frame: at baseline before study intervention and at the end of each conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

07

Study locations

1 site
  • Guillaume Debray
    Liège, Belgium
08

References and documents

Publications

  • Debray FG, Seyssel K, Fadeur M, Tappy L, Paquot N, Tran C. Effect of a high fructose diet on metabolic parameters in carriers for hereditary fructose intolerance. Clin Nutr. 2021 Jun;40(6):4246-4254. doi: 10.1016/j.clnu.2021.01.026. Epub 2021 Jan 27. PubMed 33551217 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 22, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03545581
Lead sponsor
University of Lausanne
Collaborators
University of Liege
Responsible party
Christel Tran (Principal Investigator, University of Lausanne) — Principal investigator
First posted
Jun 4, 2018
Start date
May 1, 2018
Primary completion
Dec 1, 2018
Completion
Apr 1, 2019
Last update
Apr 22, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion